SCHEMBL28436001

SCHEMBL28436001

CC(C)(C)OC(=O)N1CCSc2cc(Cl)ccc2C1

nearest known ligand 0.54

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 1/20 0.54
▸ NR1H2 P55055 1/20 0.50
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ MAPK1 P28482 1/20 0.44
▸ HDAC1 Q13547 1/20 0.43
▸ RYR2 Q92736 10/20 0.43
▸ STS P08842 3/20 0.42
▸ CYP3A4 P08684 1/20 0.39
▸ CYP3A5 P20815 1/20 0.39
▸ MKNK1 Q9BUB5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28455483 0.90 ESR2 (0.51) ESR2NR1H2MEN1KMT2AMAPK1
SCHEMBL30015973 0.85 ESR2 (0.51) ESR2NR1H2MAPK1HDAC1RYR2
SCHEMBL26654042 0.85 ESR2 (0.51) ESR2NR1H2MAPK1HDAC1RYR2
SCHEMBL30657943 0.82 KDM4E (0.49) ESR2NR1H2MAPK1HDAC1RYR2
SCHEMBL26653897 0.82 KDM4E (0.49) ESR2NR1H2MAPK1HDAC1RYR2
SCHEMBL5848351 0.82 RYR2 (0.62) ESR2NR1H2MAPK1RYR2
SCHEMBL807127 0.81 ESR2 (0.65) ESR2NR1H2MAPK1RYR2
SCHEMBL19684692 0.80 ESR2 (0.78) ESR2NR1H2MEN1KMT2AMAPK1
SCHEMBL29388008 0.80 NR1H2 (0.72) ESR2NR1H2MEN1KMT2AMAPK1
SCHEMBL31621670 0.80 ESR2 (0.78) ESR2NR1H2MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111518055-A Preparation method of benzothiazepine oxide, product prepared by preparation method and application of product 西安都创医药科技有限公司 2020-08-11 — — CN claimed
CN-111518055-A Preparation method of benzothiazepine oxide, product prepared by preparation method and application of product 西安都创医药科技有限公司 2020-08-11 — — CN disclosed
Send feedback